Enrichment of PIK3CA mutations in HPV(+) HNSCC was first noted in WES studies [50,52], which was later confirmed by another targeted sequencing study of 51 cases of mostly advanced HPV(+) HNSCC (617 cancer-associated genes [76]). This evidence concerns the gene PIK3CA and cancer.